Login Register Cart 0
Generic placeholder image

Drug Delivery Letters

Editor-in-Chief

ISSN (Print): 2210-3031
ISSN (Online): 2210-304X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Effect of Cellulose Acetate (CA-398-10 NF/ EP) on Osmotically Controlled Drug Delivery System of Amitriptyline

Author(s): Nikhil Sutar* and Preeti Karwa

Volume 12, Issue 3, 2022

Published on: 07 July, 2022

Page: [196 - 205] Pages: 10

DOI: 10.2174/2210303112666220518164608

Price: $65

Abstract

Background: Amitriptyline hydrochloride is a Tricyclic Antidepressant (TCA) belonging to BCS class I exhibiting only 30-60% bioavailability and often coupled with poor patient compliance. The primary objective was to develop a formulation with commercial viability and reduced dosing frequency in order to promote adherence of depressed patients to the treatment regime. The study also focused on reducing the dose of amitriptyline by controlling the release using osmotic technology, thereby reducing the side effects of amitriptyline.

Methods: Controlled Porosity Osmotic Pump (CPOP) systems eliminate the need for expensive drilling processes and are apt for industrial manufacturing systems, whereas other osmotic systems have practical limitations. The wet granulation technique was used to formulate CPOP tablets of amitriptyline as burst release was observed in directly compressed tablets. Screenings of polymers, osmogen and weight gain were performed.

Results: F6-D3 (3 % Di-butyl phthalate) was optimized with lactose as osmogen and HPMC K 35 M as polymer. The drug release from the optimized formulation was independent of the effect of agitational intensity and pH. The osmotic pressure of the dissolution medium was increased to confirm the osmotic release mechanism. The drug release decreased markedly due to an increase in osmotic pressure.

Conclusion: Accelerated Stability studies were carried out in ICH-certified stability chambers as per the specifications and were found stable. It was evident that osmotic pressure generated within the CPOP tablets along with the controlled formation of pores using Cellulose Acetate (CA-398-10 NF/ EP) was able to control the release of amitriptyline hydrochloride for 24 hours. Thus, the Oral Osmotic Drug Delivery system is a promising technology for product life-cycle strategies.

Keywords: Antipsychotics, tricyclic antidepressants, controlled porosity osmotic pump (CPOP) tablets, cellulose acetate, cellu-lose acetate (CA-398-10 NF / EP), osmogen.

« Previous Next »
Graphical Abstract

[1]
Sinha, K. Women More Prone to Depression than Men, Indians Worst Hit: WHO. Times of India. , Available from: http://timesofindia.indiatimes.com/india/Women-more-prone-to-depression-than-men-Indians-worst-hit-WHO/articleshow/16746142.cms(Accessed on Apr 27, 2022).
[2]
India Today Web Desk. World Happiness Report 2017: Top 10 happiest countries. India Today., 2017. Available from: http://timesoftoday.intoday.in/education/story/world-happiness-report-2017/1/91 0054.html(Accessed on Apr 27, 2022).
[3]
Helliwell, J.F.; Layard, R.; Sachs, J.; De Neve, J.E., Eds.; World Happiness Report 2021; Sustainable Development Solutions Network: New York, 2021.
[4]
Depression (major depressive disorder). (n.d.). Mayoclinic.Org Available from: http://www.mayoclinic.org/diseases-conditions/dep ression/basics/treatment/con-20032977(Accessed on Apr 27, 2022).
[5]
Gupta, B.P.; Thakur, N.; Jain, N.P.; Banweer, J.; Jain, S. Osmotically controlled drug delivery system with associated drugs. J. Pharm. Pharm. Sci., 2010, 13(4), 571-588.
[http://dx.doi.org/10.18433/J38W25] [PMID: 21486532]
[6]
Amitriptyline: Acquired long QT syndrome complicated with recurrent Torsades de Pointes: Case report. React. Wkly 2015. 1568(1), 27 Available from: http://www.drugbank.ca/drugs/DB00321 (Accessed on Apr 27, 2022).
[7]
Barbui, C.; Hotopf, M. Amitriptyline V. the rest: Still the leading antidepressant after 40 years of randomised controlled trials. Br. J. Psychiatry, 2001, 178(2), 129-144.
[http://dx.doi.org/10.1192/bjp.178.2.129] [PMID: 11157426]
[8]
Migraine prevention or recurrent headache treatment in Houston. (n.d.). Bellaireneurology.Com. Available from: http://www.bellaireneurology.com/headaches/migr_prevention.html#.UzqIbvmSzNs(Accessed on Apr 27, 2022).
[9]
Altostrata. Tips for tapering off amitriptyline. Surviving Antidepressants. 2011. Available from: http://survivingantidepressants. org/index.php?/topic/1099-tips-for-tapering-off-amitriptyline/(Accessed on Apr 27, 2022).
[10]
Kwatra, S.; Taneja, G.; Nasa, N.; Kwatra, S.; Taneja, G.; Nasa, N. Alternative routes of drug administration- transdermal, pulmonary & parenteral Indo Glob. Pharm. Sci., 2012, 2(4), 409-426.
[11]
Abdelbary, A.; El-Gazayerly, O.N.; El-Gendy, N.A.; Ali, A.A. Floating tablet of trimetazidine dihydrochloride: An approach for extended release with zero-order kinetics. AAPS PharmSciTech, 2010, 11(3), 1058-1067.
[http://dx.doi.org/10.1208/s12249-010-9468-y] [PMID: 20582493]
[12]
Patra, C.N.; Swain, S.; Sruti, J.; Patro, A.P.; Panigrahi, K.C. Basics and design approaches recent patents on drug delivery & formulation. Osmotic Drug Deliv. Syst., 2013, 7(2), 150-161.
[13]
Singla, D.; Hari Kumar, S.L. Osmotic pump drug delivery-a novel approach. Int. J. Res. Pharm. Chem., 2012, 2(3), 661-670.
[14]
Babu, C.A.; Rao, M.P.; Ratna, V.J. Controlled-porosity osmotic pump tablets- an overview. Asian J. Pharm. Res. Health Care,, 2010, 2(1), 114-126.
[15]
Brindha, V.S.; Sathali, A.A.H.; Arun, K.; Shanmuga, P. Swellable osmotic drug delivery system of amitriptyline hydrochloride–design and evaluation. J. Curr. Chem. Pharm. Sc., 2012, 2(1), 55-68.
[16]
Movassaghian, S.; Barzegar-Jalali, M.; Alaeddini, M.; Hamedyazdan, S.; Afzalifar, R.; Zakeri-Milani, P.; Mohammadi, G.; Adibkia, K. Development of amitriptyline buccoadhesive tablets for management of pain in dental procedures. Drug Dev. Ind. Pharm., 2011, 37(7), 849-854.
[http://dx.doi.org/10.3109/03639045.2010.546403] [PMID: 21231888]
[17]
Vijaya, R; Sureshkumar, S; Umamaheswari, S; Prakash, M; Senbagapriya, T; Umamaheswari, A. Preparation of amitriptyline hydrochloride films using eudragit RL 100 and hydroxyl propyl methylcellulose polymers and their in-vitro evaluation for effective transdemal delivery., 2012, 2(2), 7-15.
[18]
Rao, B.P.; Geetha, M.; Purushothama, N.; Utpal, S. Optimization and development of swellable controlled porosity osmotic pump tablet for theophylline. Trop. J. Pharm. Res., 2009, 8(3), 247-255.
[http://dx.doi.org/10.4314/tjpr.v8i3.44541]
[19]
Shah, A.; Shah, V.; Upadhyay, U.M. Development and evaluation of push-pull osmotic delivery system for ropinirole Int. J. Pharm. Sci. Res., 2012, 3(9), 3211-3218.
[20]
Patel, H.; Patel, U.; Kadikar, H.; Bhimani, B.; Daslaniya, D.; Patel, G. Formulation and evaluation of controlled porosity osmotic pump tablets of Glimepir Int. J. Drug Deliv., 2012, 4, 113-124.
[21]
Kanagale, P.; Lohray, B.B.; Misra, A.; Davadra, P.; Kini, R. Formulation and optimization of porous osmotic pump-based controlled release system of oxybutynin. AAPS PharmSciTech, 2007, 8(3), E53.
[http://dx.doi.org/10.1208/pt0803053] [PMID: 17915803]
[22]
Dasankoppa, F.S.; Ningangowdar, M.; Sholapur, H. Formulation and evaluation of controlled porosity osmotic pump for oral delivery of ketorolac. J. Basic Clin. Pharm., 2012, 4(1), 2-9.
[http://dx.doi.org/10.4103/0976-0105.109398] [PMID: 24808662]
[23]
Patel, H.; Patel, M.M. Fomulation and evaluation of controlled porosity osmotic drug delivery system of carvedilol phosphate. JPSBR, 2012, 2(2), 77-82.
[24]
Sheaikh, S.; Chandewar, A.V. Effect of various membranes and their thickness on Osmotic tablets of Eterocoxib World J. Pharm. Pharm. Sci., 2013, 2(1), 379-390.
[25]
Khairuzzaman, A.; Ahmed, S.U.; Savva, M.; Patel, N.K. Zero-order release of aspirin, theophylline and atenolol in water from novel methylcellulose glutarate matrix tablets. Int. J. Pharm., 2006, 318(1-2), 15-21.
[http://dx.doi.org/10.1016/j.ijpharm.2006.03.020] [PMID: 16621361]
[26]
Derakhshandeh, K.; Berenji, M.G. Development and optimization of buspirone oral osmotic pump tablet Res. Pharm. Sci., 2014, 9(4), 233-241.
[PMID: 25657794]
[27]
Shoaeb, M.S.; Swaroop, L.; Ayaz, A.S. Controlled porosity osmotic tablet of atenolol: In-vitro and in-vivo evaluation. Marmara Pharm. J., 2016, 20(3), 325-332.
[http://dx.doi.org/10.12991/mpj.20162040694]
[28]
Liu, H.; Yang, X.G.; Nie, S.F.; Wei, L.L.; Zhou, L.L.; Liu, H.; Tang, R.; Pan, W.S. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: Screening of formulation variables and in vitro investigation. Int. J. Pharm., 2007, 332(1-2), 115-124.
[http://dx.doi.org/10.1016/j.ijpharm.2006.09.038] [PMID: 17052871]
[29]
Theeuwes, F. Elementary osmotic pump. J. Pharm. Sci., 1975, 64(12), 1987-1991.
[http://dx.doi.org/10.1002/jps.2600641218] [PMID: 1510]
[30]
Rani, M.; Mishra, B. Comparative in vitro and in vivo evaluation of matrix, osmotic matrix, and osmotic pump tablets for controlled delivery of diclofenac sodium. AAPS PharmSciTech, 2004, 5(4), e71.
[http://dx.doi.org/10.1208/pt050471] [PMID: 15760068]
[31]
Nokhodchi, A.; Farid, D.J.; Najafi, M.; Adrangui, M. Studies on controlled-release formulations of diclofenac sodium. Drug Dev. Ind. Pharm., 1997, 23(11), 1019-1023.
[http://dx.doi.org/10.3109/03639049709150490]
[32]
Tiwari, S.B.; Murthy, T.K.; Pai, M.R.; Mehta, P.R.; Chowdary, P.B. Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system. AAPS PharmSciTech, 2003, 4(3), E31.
[http://dx.doi.org/10.1208/pt040331] [PMID: 14621963]
[33]
Traconis, N.; Rodriguez, R.; Campos, M.E.; Villafuerte, L. Influence of admixed polymers on the metronidazole release from hydroxypropyl methylcellulose matrix tablets. Pharm. Acta Helv., 1997, 72(3), 131-138.
[http://dx.doi.org/10.1016/S0031-6865(97)00007-1]
[34]
Catellani, P.L.; Colombo, P.; Peppas, N.A.; Santi, P.; Bettini, R. Partial permselective coating adds an osmotic contribution to drug release from swellable matrixes. J. Pharm. Sci., 1998, 87(6), 726-731.
[http://dx.doi.org/10.1021/js9800026] [PMID: 9607950]
[35]
Verma, R.K.; Mishra, B.; Garg, S. Osmotically controlled oral drug delivery. Drug Dev. Ind. Pharm., 2000, 26(7), 695-708.
[http://dx.doi.org/10.1081/DDC-100101287] [PMID: 10872087]
[36]
Bindschaedler, C.; Gurny, R.; Doelker, E. Osmotically controlled drug delivery systems produced from organic solutions and aqueous dispersions of cellulose acetate. J. Control. Release, 1986, 4(3), 203-212.
[http://dx.doi.org/10.1016/0168-3659(86)90004-0]
[37]
Ramakrishna, N.; Mishra, B. Plasticizer effect and comparative evaluation of cellulose acetate and ethylcellulose-HPMC combination coatings as semipermeable membranes for oral osmotic pumps of naproxen sodium. Drug Dev. Ind. Pharm., 2002, 28(4), 403-412.
[http://dx.doi.org/10.1081/DDC-120003001] [PMID: 12056533]

Rights & Permissions Print Cite
Article Metrics
3
© 2024 Bentham Science Publishers | Privacy Policy